ObjectiveThe objective of this study was to assess the histopathological reports from excision treatment and biopsy to identify the prevalence of CIN2+ among a cohort of women who had abnormal cervical cancer visual screening reports in Cameroon and to identify potential risk factors for CIN2+.MethodsThis was a cross-sectional study using secondary data from women who underwent cervical cancer visual screening and provided tissue through excision treatment or biopsy between 2007-2023 in Cameroon. The program nurses provided a presumptive pathologic diagnosis which was compared with the final pathologic diagnosis. We described baseline characteristics by estimating means, standard deviations (SD), counts, and percentages for continuous and categorical variables, as appropriate. T-tests and chi square tests were used to compare continuous and categorical variables, respectively, between women with CIN2+ and women without CIN2+.ResultsOf the 1,294 women, 930 (71.1%) had CIN2+ while 364 (28.1%) had no CIN2+. Age, visual screening results, and HIV status were significant predictors of CIN2+. Of the 724 women with lesions suspicious for Invasive Cervical Cancer (ICC), 545 (75.3%) had ICC while 53 (7.3%) had CIN3. Of the 227 women who had excision treatment, 70 (30.8%) had CIN3, followed by 53 (23.4%) with CIN2. The agreement between nurses’ presumptive pathologic diagnosis and final pathologic diagnosis was fair (0.356).ConclusionThe prevalence of CIN2+ was over 70%. In our cohort, age, HIV status, and visual screening results were strong clinical predictors for CIN2+. Nurse-led triage shows good reliability in identifying ICC.